Maxis AI · Published 2025-06-09

How Agentic AI Is Transforming Clinical Trials | Maxis AI Podcast

Open on YouTube ↗

Summary

Overview

  • Speaker: Moulik Shah
  • Channel: Maxis AI
  • Main topic: Agentic AI in Clinical Trials
  • Purpose: To educate industry professionals on the transformative impact of agentic AI in clinical trials, dispel common myths, and introduce Maxis AI's enterprise-grade platform. The podcast explores how agentic AI agents developed by Maxis AI are revolutionizing clinical trials by enhancing efficiency, accuracy, and operational innovation. Host Nicole Powell and guest Moulik Shah, founder and CEO of Maxis AI, discuss the evolution of AI from traditional narrow automation and generative AI into goal-oriented agentic AI that can reason, collaborate, act, and adapt.

Topic Map

Definition and Evolution of Agentic AI

  • Explanation: Explains how agentic AI builds on generative AI and traditional automation by introducing goal-oriented digital workers capable of reasoning, acting, and adapting to process complexities.
  • Key claims:
    • Agentic AI is the next technological advancement on top of generative AI.
    • Traditional automation is narrow, rule-based, and rigid.
    • Agentic AI uses large language models with vast intelligence to drive intelligent, goal-oriented automation.
  • Examples:
    • Self-driving cars acting as agents directed by traffic control systems.
  • Terminology:
    • Agentic AI
    • Generative AI
    • Large Language Models (LLMs)
    • Orchestration
  • Why it matters: It shifts operational models from reactive decision-making to proactive, automated goal achievement.

Reimagining Clinical Trial Operating Models

  • Explanation: Discusses the increasing complexity of clinical trials, the flaws of legacy paper-based or reactive systems, and why the industry must adopt agentic AI to reverse diminishing productivity trends.
  • Key claims:
    • Clinical trials face increasing complexity, dynamic decision-making, and rising costs.
    • Legacy operating models rely on reactive decision-making and manual processes.
    • Productivity in drug development faces the reverse of Moore's Law, where costs rise and productivity declines.
  • Examples:
    • Transitioning from paper-based trials to electronic systems without optimizing operational workflows.
  • Terminology:
    • Eroom's Law
    • Operational Complexity
    • Risk Mitigation
  • Why it matters: Adopting agentic AI is essential to handle complex, precision-oriented tiny trials and reduce operational costs.

Maxis AI Platform and Agent Capabilities

  • Explanation: Introduces Maxis AI's enterprise-grade platform, which provides verified agents for tasks ranging from content generation to data management, anomaly detection, and reporting.
  • Key claims:
    • Maxis AI empowers the life sciences industry to build and deploy their own enterprise-grade agents.
    • The platform supports observability, security, scalability, and interoperability.
    • Agents can operate autonomously or in collaboration with human knowledge workers.
  • Examples:
    • Content generation, data management, anomaly detection, data transformation, and reporting agents.
  • Terminology:
    • Enterprise-grade platform
    • Multi-agent digital ecosystem
    • Human-in-the-loop
  • Why it matters: It enables organizations to shift from a rigid linear resource model to doing more with less.

Enhancing Risk Monitoring and Patient Safety

  • Explanation: Examines how agentic AI transforms risk monitoring from a reactive, periodic process into a continuous, real-time, proactive safeguard for clinical trials.
  • Key claims:
    • Traditional risk monitoring is reactive, relying on post-collection data analysis.
    • Agentic AI agents continuously scan EDC and lab systems for patterns and anomalies 24/7.
    • Agents provide real-time risk scoring and recommended mitigation actions to site owners and CROs.
  • Examples:
    • Real-time tracking of enrollment delays and quality risk profiling.
  • Terminology:
    • Risk-Based Monitoring (RBM)
    • Operational Risk
    • Quality Risk
  • Why it matters: Continuous monitoring significantly reduces trial delays, safety risks, and operational costs.

Debunking Common Myths About Agentic AI

  • Explanation: Addresses three major myths: that agentic AI means full autonomy without human oversight, that AI is untrustworthy, and that AI will eliminate human jobs.
  • Key claims:
    • Myth 1: Agentic AI is purely autonomous like self-driving cars; in reality, it supports flexible human-in-the-loop collaboration.
    • Myth 2: AI is untrustworthy; LLMs can be fine-tuned with business context, governance, and guardrails to ensure reliability.
    • Myth 3: AI will eliminate jobs; while roles change and become more strategic, jobs are transformed rather than eliminated.
  • Examples:
    • Historical industrial revolutions transforming rather than destroying workforce opportunities.
  • Terminology:
    • Human-in-the-loop
    • Fine-tuning
    • Governance guardrails
  • Why it matters: Dispelling these myths helps enterprises overcome hesitation and adopt AI faster.

Adoption Strategy for Clinical Trial Teams

  • Explanation: Provides actionable guidance on how clinical trial teams should start integrating agentic AI by beginning small, scaling fast, and focusing on high-impact use cases.
  • Key claims:
    • Start small but scale fast by focusing on high-impact use cases.
    • Prioritize reusable capabilities and leverage wider API ecosystems rather than building everything from scratch.
    • Data strategy and clean data governance beat big data volume every time.
  • Examples:
    • Building reusable platform capabilities across multiple trial geographies and use cases.
  • Terminology:
    • Data Strategy
    • API Ecosystem
    • Proof of Concept (POC)
  • Why it matters: Following a structured platform strategy prevents pilot purgatory and ensures successful production adoption.

Key Points

Agentic AI goes beyond traditional automation and generative AI

  • Explanation: It introduces goal-oriented software entities that can reason, collaborate, act, and adapt to changing workflows autonomously or with human collaboration.
  • Evidence: Comparison with self-driving car orchestration systems and LLM intelligence pools.
  • Practical implication: Enterprises can execute complex workflows with fewer human bottlenecks.

Reversing Eroom's Law in Clinical Trials

  • Explanation: Pharmaceutical research faces rising costs and decreasing productivity, making legacy operational models unsustainable for precision-oriented, multiple tiny trials.
  • Evidence: Historical shift from paper to electronic systems failed to eliminate reactive decision-making complexity.
  • Practical implication: Agentic AI improves throughput per human capacity, driving costs down.

Proactive 24/7 Risk Monitoring

  • Explanation: Instead of periodic manual reviews, AI agents continuously scan clinical data systems to detect anomalies and recommend real-time mitigation strategies.
  • Evidence: Continuous scanning of EDC and labs for quality and operational risks.
  • Practical implication: Significantly lowers trial cycle times and prevents enrollment or compliance delays.

Debunking the Job Elimination Myth

  • Explanation: AI transforms roles to be more strategic and oversight-driven rather than eliminating the workforce, much like past industrial revolutions.
  • Evidence: Historical precedence of industrial transformations creating new job categories.
  • Practical implication: Workers are empowered to focus on higher-value strategy while AI manages operational burdens.

Frameworks, Models & Processes

Maxis AI Enterprise-Grade Agentic Platform

  • How it works: Combines pre-verified and custom-built AI agents with enterprise governance, observability, and APIs to orchestrate end-to-end clinical trial workflows.
  • Components:
    • Content Generation Agents
    • Data Management & Anomaly Detection Agents
    • Data Transformation & Reporting Agents
    • Human-in-the-Loop Governance Guardrails
  • When to use: When scaling clinical trial operations, managing complex data streams, and transitioning from reactive to proactive risk management.

Examples & Case Studies

Autonomous vehicles operating under traffic control systems

  • Illustrates: Multi-agent orchestration where individual agents work towards a common goal while supervised by a superior control system
  • Lesson: Agentic AI requires both autonomous agent capabilities and higher-level orchestration to avoid collisions and optimize flow.

Actionable Takeaways

  • Immediate:
    • Start small and scale fast with high-impact clinical trial use cases.
    • Focus on clean data governance rather than massive data volume.
    • Leverage existing API ecosystems and modular platform capabilities.
  • Strategic:
    • Shift clinical operations from reactive decision-making to proactive, AI-driven risk mitigation.
    • Embrace agentic AI platforms to empower knowledge workers and reverse Eroom's Law.
    • Build a resilient organizational culture that bridges the gap between technology and business.
  • Questions to investigate:
    • What are the highest-impact initial use cases for agentic AI in our clinical trials?
    • How do we establish robust governance and audit trails for AI-driven risk recommendations?
    • How can we transition our team from legacy operating models to a hybrid workforce ecosystem?

Claims Worth Verifying

  • Agentic AI platforms can continuously monitor clinical trial EDC and lab data 24/7 to predict operational risks in real time. (technical capability)
  • Eroom's Law describes the exponential and mounting cost of discovering and bringing a new drug to market over time. (industry trend)

Notable Quotes

"Agentic AI is a next technological advancement on top of generative AI." "The best time to adopt agentic AI was yesterday, and the second best time is today." "Roles are becoming more strategic now... your ability to think beyond a specific scenario is unleashed."

Compressed Summary

  • Agentic AI combines generative AI with goal-oriented autonomous reasoning and orchestration.
  • Clinical trials suffer from Eroom's Law, where operational complexity and costs continually rise.
  • Maxis AI provides an enterprise platform enabling companies to build, buy, and orchestrate specialized AI agents.
  • AI agents enable 24/7 proactive risk monitoring, anomaly detection, and real-time mitigation guidance.
  • Successful adoption requires starting small with high-impact use cases, clean data governance, and cultural alignment.
  • Keywords: agentic ai, clinical trials, maxis ai, risk monitoring, llm orchestration
  • Core insight: Agentic AI transforms clinical trials by replacing reactive, manual operating models with proactive, multi-agent orchestration that drives efficiency, lowers costs, and improves patient safety.

Core insights

7
Mental Modelmedium noveltymoderate evidence

Agentic AI is positioned not as a replacement abstraction for automation and generative AI, but as a layer stacked on top of both: the LLM supplies open-ended reasoning while orchestration supplies goal direction, so the agent is a goal-directed composite rather than a smarter model.

Why it matters

Framing the agent as an orchestration-plus-LLM composite (rather than a model property) determines where engineers put the goal state, planner, and control loop; it implies the hard engineering work lives in orchestration and goal specification, not in the model itself.

Generalization

Any agentic system can be decomposed into a reasoning substrate plus an orchestration layer that owns goals; evaluating one without the other is an incomplete evaluation.

Agentic AI is the next technological advancement on top of generative AI.
Open source video
Agentic AI uses large language models with vast intelligence to drive intelligent, goal-oriented automation.
Open source video
Self-driving cars acting as agents directed by traffic control systems.
Open source video
Architecturemedium noveltymoderate evidence

Risk monitoring shifts from a periodic, post-collection batch review (analyze data after it lands in the system) to a continuous 24/7 scan of upstream source systems (EDC, labs) that emits real-time risk scores plus recommended mitigation actions routed to specific owners such as site owners and CROs.

Why it matters

This changes the integration boundary: agents must hook into live operational systems of record and produce not just alerts but ranked scores and action recommendations addressed to accountable humans. That requires event/stream ingestion, anomaly scoring, action-recommendation generation, and a routing/escalation surface — a materially different subsystem than a reporting pipeline.

Generalization

Monitoring agents are most valuable when they read directly from the systems where work happens and emit an action plus an owner, rather than emitting a report after the fact.

Traditional risk monitoring is reactive, relying on post-collection data analysis.
Open source video
Agentic AI agents continuously scan EDC and lab systems for patterns and anomalies 24/7.
Open source video
Agents provide real-time risk scoring and recommended mitigation actions to site owners and CROs.
Open source video
Architecturemedium noveltymoderate evidence

The proposed autonomy model is explicitly graduated: agents may run autonomously or in collaboration with human knowledge workers, and the human-in-the-loop is treated as a configurable flexibility rather than a fixed architectural constraint.

Why it matters

If humans are intervenable at variable points rather than a mandatory gate, the agent runtime needs per-task autonomy configuration, escalation policy, and state handoff to the human — effectively a control plane for autonomy level. That is different from either fully manual or fully autonomous pipelines.

Generalization

Agent runtimes should treat autonomy level as runtime configuration with defined escalation and handback semantics, since the appropriate level varies per task and risk class.

Agents can operate autonomously or in collaboration with human knowledge workers.
Open source video
Agentic AI is purely autonomous like self-driving cars; in reality, it supports flexible human-in-the-loop collaboration.
Open source video
Practicelow noveltyweak evidence

Trustworthiness is framed as a configuration problem, not a model-selection problem: reliability is pursued by fine-tuning LLMs with business context and wrapping them in governance and guardrails, i.e., domain grounding plus policy enforcement.

Why it matters

This points engineers toward context injection and policy-boundary enforcement as the primary reliability levers, rather than swapping to a bigger model — a concrete, testable design stance for high-stakes domains.

Generalization

In regulated or high-stakes domains, reliability engineering concentrates on domain grounding and enforced constraints around a general model rather than solely on model capability.

AI is untrustworthy; LLMs can be fine-tuned with business context, governance, and guardrails to ensure reliability.
Open source video
Practicemedium noveltymoderate evidence

The claimed adoption strategy is asymmetric: start small on high-impact use cases but scale fast, prioritizing reusable platform capabilities and external API ecosystems over building components from scratch, with data cleanliness/governance ranked above data volume.

Why it matters

This inverts the common enterprise habit of proving value once and then rebuilding integration for each new use case. Reusability-plus-API-composition is a concrete hedge against the named failure mode of getting stuck in a pilot.

Generalization

Agent-platform success correlates more with reuse and clean data governance than with data volume or bespoke per-use-case builds; treat pilots as capability accrual rather than one-off demos.

Start small but scale fast by focusing on high-impact use cases.
Open source video
Prioritize reusable capabilities and leverage wider API ecosystems rather than building everything from scratch.
Open source video
Data strategy and clean data governance beat big data volume every time.
Open source video
Following a structured platform strategy prevents pilot purgatory and ensures successful production adoption.
Open source video
Empirical Resultmedium noveltymoderate evidence

The stated motivation is an economic productivity inversion (Eroom's Law) in which shifting from paper to electronic systems did not remove reactive decision-making complexity — digitizing a workflow without changing its decision model left the underlying cost structure intact.

Why it matters

This is a direct warning about technology-layer substitutions that digitalize inputs but preserve human-in-the-loop decision latency. It suggests the measurable target is throughput per human capacity, not system modernization itself.

Generalization

Digitization without changing the decision model yields limited productivity gains; the gain comes from replacing or augmenting reactive decision steps, not from moving data to electronic form.

Productivity in drug development faces the reverse of Moore's Law, where costs rise and productivity declines.
Open source video
Transitioning from paper-based trials to electronic systems without optimizing operational workflows.
Open source video
Historical shift from paper to electronic systems failed to eliminate reactive decision-making complexity.
Open source video
Predictionlow noveltyweak evidence

The job-elimination myth is answered by claiming role transformation toward more strategic work, with the industrial revolution offered as the historical precedent — an asserted analogy rather than a measured outcome.

Why it matters

If roles transform rather than disappear, the operational requirement becomes redesigning human work to absorb upgraded agent output (reviewing scores, approving recommendations) rather than simply automating steps away — which changes interface and workload design.

Generalization

Where agents absorb execution, the durable human contribution shifts to judgment and exception handling, so interfaces must be built for reviewing and overriding agent output.

AI will eliminate jobs; while roles change and become more strategic, jobs are transformed rather than eliminated.
Open source video
Historical industrial revolutions transforming rather than destroying workforce opportunities.
Open source video

Deep dives

4

A per-task autonomy policy control plane for agents

Research question

What minimal policy specification (thresholds, escalation triggers, approval gates, handback state) lets one agent runtime switch between autonomous execution and human collaboration per task, and how does it change review burden vs. throughput?

Why

The talk treats human-in-the-loop as configurable flexibility, not a fixed gate. That means autonomy has to be a runtime property with explicit escalation and handback semantics — a control plane — otherwise teams either over-gate (reintroducing the human latency they were removing) or under-gate (removing oversight a regulated domain requires). Without a specified policy format, the claim is unfalsifiable.

Agents can operate autonomously or in collaboration with human knowledge workers.
Open source video
Agentic AI is purely autonomous like self-driving cars; in reality, it supports flexible human-in-the-loop collaboration.
Open source video
Self-driving cars acting as agents directed by traffic control systems.
Open source video
Source video

Alert quality and calibration for continuous upstream risk monitoring

Research question

What precision/recall and false-positive rate must a 24/7 anomaly-scanning agent hold before the sustained alert stream costs less in review effort than the periodic post-collection review it replaces?

Why

Continuous scanning is only an improvement if alert quality stays above the point where human reviewers can absorb the stream. The talk asserts real-time scoring and recommended mitigations but gives no accuracy, alert-volume, or calibration evidence, so the net-benefit claim is currently an argument, not a result. This is the single number that determines whether the architecture change pays off.

Traditional risk monitoring is reactive, relying on post-collection data analysis.
Open source video
Agentic AI agents continuously scan EDC and lab systems for patterns and anomalies 24/7.
Open source video
Agents provide real-time risk scoring and recommended mitigation actions to site owners and CROs.
Open source video
Source video

Verification harness for regulated-domain agents

Research question

What verification procedure — correctness tests, guardrail-compliance checks, auditability artifacts — should precede deployment of an agent that can act on trial data, and at what residual failure rate is it acceptable?

Why

The platform is described as offering 'verified agents,' but the verification procedure is unspecified. In a regulated domain, verification is the deployment gate, so 'verified' must decompose into measurable test classes and acceptance thresholds. This also determines whether guardrails plus context grounding actually reduce errors enough at the decision boundary.

AI is untrustworthy; LLMs can be fine-tuned with business context, governance, and guardrails to ensure reliability.
Open source video
The platform supports observability, security, scalability, and interoperability.
Open source video
Maxis AI empowers the life sciences industry to build and deploy their own enterprise-grade agents.
Open source video
Source video

Where the engineering work lives in an orchestration-plus-LLM agent

Research question

If an agent is a reasoning substrate plus an orchestration layer that owns goals, do gains on goal-directed adaptive tasks come from the orchestration layer (goal state, planner, control loop) rather than from model capability — and how do you isolate the two when evaluating?

Why

Framing the agent as a composite rather than a model property relocates the hard engineering work to orchestration and goal specification, and implies that evaluating the model alone is an incomplete evaluation. This has direct consequences for where a team invests and what its eval harness must hold constant.

Agentic AI is the next technological advancement on top of generative AI.
Open source video
Agentic AI uses large language models with vast intelligence to drive intelligent, goal-oriented automation.
Open source video
Self-driving cars acting as agents directed by traffic control systems.
Open source video
Source video

Article ideas

4

Digitizing a Workflow Doesn't Fix Eroom's Law — Replacing Reactive Decisions Does

The paper-to-electronic transition failed to change trial cost curves because it moved data capture without changing the decision model; agentic AI only produces productivity gains where it removes or augments reactive decision steps, and the honest metric is throughput per human capacity, not modernization.

Angle

Treat the historical electronic-systems shift as a controlled natural experiment in technology substitution without workflow redesign, and derive the design rule for agent deployments from what it failed to change.

Source video

Your Monitoring Agent Is a Report Generator Until It Emits an Owner

Monitoring agents only become decision support when they read directly from the systems where work happens and emit a ranked action addressed to an accountable human, which forces ingestion, scoring, recommendation, and routing/escalation to be built as one subsystem rather than added as a reporting pipeline.

Angle

Architecture teardown of the boundary change from post-collection batch review to live source-system scanning, with the integration contract as the deliverable.

Source video

Autonomy Is a Configuration, Not a Mode

Framing agentic systems as either autonomous or human-in-the-loop is the wrong axis; autonomy belongs in a per-task policy layer with defined escalation and handback semantics, and the design question is what that policy must specify to be auditable.

Angle

Argue against the fully-autonomous myth by showing what a runtime needs when humans are intervenable at variable points instead of a mandatory gate.

Source video

Reuse Rate Is the Only Agent-Platform KPI That Prevents Pilot Purgatory

The pilot-to-production failure mode is not weak model accuracy but treating each pilot as a one-off demo; if capabilities are not built once as platform assets and composed through existing APIs, small-and-fast scaling is impossible, so reuse rate should be instrumented as a first-class metric alongside accuracy.

Angle

Invert the usual per-pilot accuracy dashboard and propose reuse across geographies and use cases as the leading indicator, with clean data governance ranked above data volume.

Source video

Project ideas

4

Autonomy Policy Layer Prototype

gatehouse

Making autonomy level an explicit per-task policy with escalation triggers and handback state reduces human review minutes per completed task without increasing error-escape rate, compared with a single system-wide approval gate.

Proof of concept

Wrap a small set of trial-operations agent tasks (e.g., anomaly triage, data transformation) in a policy layer that declares autonomy level, escalation conditions, and handback state transfer; route low-risk tasks autonomously and gate high-risk tasks to a reviewer with transferred context.

Measurement

Review minutes per task, task throughput, and error-escape rate (agent actions later reversed) with the policy layer on vs. a fixed approval gate off.

Source video

Anomaly Injection Benchmark for Continuous Trial Monitoring

beyond-evals

Continuous scanning of source-system data detects injected anomalies faster than periodic post-collection review, but only above an alert-rate ceiling where reviewer capacity absorbs the stream.

Proof of concept

Build trial-like data with known injected anomalies, run both a continuous 24/7 scanning loop and a periodic post-collection review, and sweep the scoring threshold to trace the sensitivity/alert-volume curve.

Measurement

Detection sensitivity and time-to-detection vs. alerts per reviewer-day (alert fatigue cost), with the threshold at which continuous scanning stops paying off.

Source video

Regulated-Domain Agent Verification Harness

gatehouse

A verification harness that separates correctness, guardrail-compliance, and auditability test classes yields a reproducible residual failure rate per agent capability, and context grounding plus enforced constraints lowers it more than model capability increases do.

Proof of concept

Define acceptance test classes for a set of trial-operations agent capabilities, run them against (a) a base model with guardrails and business context and (b) a larger model without domain grounding, and compare failure modes by class.

Measurement

Residual failure rate per test class, share of failures attributable to guardrail violations vs. capability gaps, and reproducibility of results across repeated runs.

Source video

Reuse-Rate Instrumentation for an Agent Platform

movement-lab

Tracking capability reuse across use cases and geographies predicts which pilots reach production, and governing data cleanliness raises agent task success more than adding raw data volume.

Proof of concept

Instrument an agent platform so each capability records which use cases consume it, then correlate reuse patterns with pilot outcomes while holding model and task constant across a clean-data vs. large-data comparison.

Measurement

Reuse rate per capability, correlation between reuse rate and pilot-to-production promotion, and delta in task success from clean data vs. additional raw data volume.

Source video

Architectural implications

3

Risk monitoring is reframed from a reporting subsystem to a live decision-support loop connected to operational systems of record and to named human owners.

Before

Data collected, then periodically analyzed and reported after the fact.

After

Agents continuously scan EDC and lab systems, score risk in real time, and push recommended mitigations to site owners and CROs.

Consequence

Requires event/stream ingestion into source systems, an anomaly/risk scoring service, an action-recommendation generator, and routing/escalation to accountable humans; observability must cover alert quality, not just uptime.

Source video

Autonomy is treated as a tunable property of the task rather than a fixed system-wide mode.

Before

A pipeline is either automated or human-driven.

After

Agents operate autonomously or alongside human knowledge workers depending on the task.

Consequence

The runtime needs an autonomy/approval policy layer with escalation and handback semantics, plus state transfer to the human reviewer.

Source video

Enterprise agent value is argued to come from reusable platform capabilities and API ecosystems rather than bespoke per-use-case builds.

Before

Each trial or geography gets its own purpose-built automation.

After

Capabilities are built once as platform assets and composed via existing APIs.

Consequence

Platform investment is justified by reuse across geographies and use cases; instrumentation should measure reuse rate, not just per-pilot accuracy.

Source video

Tradeoffs and failure modes

4

Full autonomy vs. human-in-the-loop

Benefit

Agents can act without waiting on human bottlenecks for high-volume operational work.

Cost or risk

Treating agentic AI as fully autonomous is named a myth; uncritical autonomy risks removing oversight the domain requires, while excessive oversight reintroduces the human latency the system was meant to remove.

Agentic AI is purely autonomous like self-driving cars; in reality, it supports flexible human-in-the-loop collaboration.
Open source video
Source video

Digitization vs. workflow redesign

Benefit

Moving from paper to electronic systems modernizes capture and data availability.

Cost or risk

Without optimizing operational workflows, digitization preserves reactive decision-making and the complexity and cost structure it was meant to remove.

Transitioning from paper-based trials to electronic systems without optimizing operational workflows.
Open source video
Source video

Data volume vs. data governance

Benefit

Large data stores promise more signal for models.

Cost or risk

The speaker asserts clean data strategy and governance beat volume, implying volume without governance adds cost and noise rather than reliability.

Data strategy and clean data governance beat big data volume every time.
Open source video
Source video

Pilot-to-production transition

Benefit

Starting small on high-impact use cases is low risk and demonstrates value quickly.

Cost or risk

The stated failure mode is getting stuck in 'pilot purgatory' when small pilots are not built as reusable platform capabilities.

Following a structured platform strategy prevents pilot purgatory and ensures successful production adoption.
Open source video
Source video

Open questions

5

What concrete autonomy/escalation policy determines whether an agent acts or hands off to a human, and how is that policy specified and audited?

Why unresolved

The summary asserts flexible human-in-the-loop collaboration but gives no mechanism for encoding thresholds, approval gates, or handback state.

Research direction

Prototype a per-task autonomy policy layer with explicit escalation triggers and measure review burden vs. throughput.

Source video

How are real-time risk scores validated — what precision/recall and false-positive rate is acceptable when agents continuously scan EDC and lab systems for anomalies?

Why unresolved

Continuous 24/7 scanning implies a sustained alert stream, but the summary provides no accuracy, alert-volume, or calibration evidence.

Research direction

Build a benchmark of injected anomalies in trial-like data and measure detection sensitivity versus alert fatigue cost.

Source video

What ingestion and interoperability contract is needed to scan upstream systems (EDC, labs) continuously rather than reading post-collection extracts?

Why unresolved

The summary names EDC and lab systems as targets but does not describe APIs, event formats, latency requirements, or access controls.

Research direction

Define an event-based connector specification for trial source systems and measure end-to-end detection latency.

Source video

Is there measurable evidence that agentic AI reverses declining drug-development productivity, or is the Eroom's Law linkage an argument rather than a result?

Why unresolved

The productivity inversion is cited as industry context; no measured throughput-per-human-capacity figure is given.

Research direction

Identify throughput-per-FTE metrics in trial operations and instrument before/after agent deployment.

Source video

What does 'verified agents' mean operationally — what verification, testing, or certification process precedes deployment?

Why unresolved

The platform is described as providing 'verified agents' with observability and security, but the verification procedure is not specified.

Research direction

Specify a verification harness for regulated-domain agents covering correctness, guardrail compliance, and auditability.

Source video

Key claims

8
comparativeVerification needed

Agentic AI is the next advancement layered on top of generative AI, using LLMs to drive goal-oriented automation where earlier automation was narrow and rule-based.

Evidence

Agentic AI is the next technological advancement on top of generative AI.

Question

Does an orchestration-plus-LLM composite measurably outperform rule-based automation on goal-directed tasks that require adaptation?

Source video
comparativeVerification needed

Traditional risk monitoring is reactive and depends on post-collection data analysis, whereas agents continuously scan EDC and lab systems 24/7.

Evidence

Traditional risk monitoring is reactive, relying on post-collection data analysis.

Question

What latency and detection-rate improvement does continuous scanning produce over periodic post-collection review?

Source video
causalVerification needed

Agents deliver real-time risk scoring and recommended mitigation actions to site owners and CROs.

Evidence

Agents provide real-time risk scoring and recommended mitigation actions to site owners and CROs.

Question

Do recipients act on agent-recommended mitigations, and does acting on them reduce trial delays?

Source video
factualVerification needed

Drug development productivity moves in the reverse of Moore's Law: costs rise while productivity declines.

Evidence

Productivity in drug development faces the reverse of Moore's Law, where costs rise and productivity declines.

Question

What per-period cost and productivity trend data support the Eroom's Law characterization for current clinical trials?

Source video
causalVerification needed

The move from paper to electronic trial systems failed to eliminate reactive decision-making complexity because operational workflows were not optimized.

Evidence

Historical shift from paper to electronic systems failed to eliminate reactive decision-making complexity.

Question

Did electronic-system adoption change decision latency or cost per trial, controlling for workflow redesign?

Source video
opinionVerification needed

Reliability concerns about LLMs are addressable by fine-tuning with business context and adding governance and guardrails.

Evidence

AI is untrustworthy; LLMs can be fine-tuned with business context, governance, and guardrails to ensure reliability.

Question

Do fine-tuning plus guardrails reduce error rates enough for regulated trial decisions, and at what residual failure rate?

Source video
predictionVerification needed

Agentic AI transforms rather than eliminates jobs, shifting roles toward more strategic work.

Evidence

AI will eliminate jobs; while roles change and become more strategic, jobs are transformed rather than eliminated.

Question

After agent deployment, how do headcount, role mix, and per-role output change in trial operations teams?

Source video
opinionVerification needed

Clean data strategy and governance matter more than data volume for agentic adoption.

Evidence

Data strategy and clean data governance beat big data volume every time.

Question

Holding model and task constant, how much does data cleanliness improve agent task success versus adding more raw data?

Source video

Connections

5